P1.05-015 Major Pathological Response as a Predictive Value of Survival in Early-Stage NSCLC After Chemotherapy: Cohort of NATCH Phase III Trial by Carcereny, E., Martinez, A., Mate, J.L., Sansano, J., Pardo, N., Estival, A., Navarro, A., De Castro, A. Martinez, Zeron-Medina, J., Vielva, L. Romero, Morán, T., Cedres, S., Felip, E.

Get full text